Allan Jensen

Allan Jensen is a seasoned professional in the biopharmaceutical industry with extensive experience spanning over two decades. Currently serving as Vice President at Lundbeck since October 2016, Allan has held multiple leadership roles, including Senior Director of Biotherapeutic Discovery and Director, Head of Biologics. Prior to Lundbeck, Allan was the Chief Scientific Officer at HiFiBiO from September 2014 to September 2016 and held various director positions at Pfizer from October 2009 to August 2014, focusing on Science & Technology and Human BioResponses. Earlier in the career at Symphogen, Allan was Director of Antibody Discovery and a Senior Scientist, contributing to research and development from May 2003 to October 2009. The professional journey began as a Research Scientist at Pharmexa (1998-2001), followed by a Principal Scientist role at Inoxell (2001-2003). Academic credentials include a Ph.D. in Molecular Biology from Aarhus University, where Allan studied from 1988 to 1998, and completion of an education program at Pathfinder in 2007.